Personal profile
Flemish discipline codes in use since 2023
- Other basic sciences not elsewhere classified
Fingerprint
Dive into the research topics where Christiane Knoop is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
The Proof of the Pudding Is in the Eating: Real-Life Intra- and Extrapulmonary Impact of Elexacaftor/Tezacaftor/Ivacaftor
Vincken, S., Verbanck, S., Braun, S., Buyck, N., Zienebergh, C., Knoop, C. & Vanderhelst, E., Jan 2025, In: Respiration. 104, 6, p. 388-396 9 p.Research output: Contribution to journal › Article › peer-review
-
Psychosocial impact of 6 months of treatment with Symkevi® among adult cystic fibrosis patients
Braun, S., Eyns, H., Verbanck, S., Vanderhelst, E., Knoop, C., De Wachter, E. & Vincken, S. R., 2022, In: Journal of Cystic Fibrosis. 21, Supplement 1, p. 138-139 2 p., (s134) P243.Research output: Contribution to journal › Meeting abstract (Journal)
-
Emergence of livestock-associated MRSA isolated from cystic fibrosis patients: Result of a Belgian national survey
Dodémont, M., Argudín, M. A., Willekens, J., Vanderhelst, E., Pierard, D., Miendje Deyi, V. Y., Hanssens, L., Franckx, H., Schelstraete, P., Leroux-Roels, I., Nonhoff, C., Deplano, A., Knoop, C., Malfroot, A. & Denis, O., Jan 2019, In: Journal of Cystic Fibrosis. 18, 1, p. 86-93 8 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile18 Citations (Scopus)82 Downloads (Pure) -
The clinical benefits of long-term supplementation with omega-3 fatty acids in cystic fibrosis patients - A pilot study
Hanssens, L., Thiébaut, I., Lefèvre, N., Malfroot, A., Knoop, C., Duchateau, J. & Casimir, G., May 2016, In: Prostaglandins, Leukotrienes & Essential Fatty Acids. 108, p. 45-50 6 p.Research output: Contribution to journal › Article › peer-review
25 Citations (Scopus) -
Ataluren for the treatment of nonsense-mutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trial
Kerem, E., Konstan, M., De Boeck, K., Accurso, F., Sermet-Gaudelus, I., Wilschanski, M., Elborn, J., Melotti, P., Bronsveld, I., Fajac, I., Malfroot, A., Rosenbluth, D., Walker, P., Mccolley, S., Knoop, C., Quattrucci, S., Rietschel, E., Zeitlin, P., Barth, J. & Elfring, G. & 6 others, , 2014, In: The Lancet Respiratory Medicine. 2, 2014 Jul, p. 539-547 9 p.Research output: Contribution to journal › Article › peer-review
307 Citations (Scopus)